20
Growth Score
pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Delmont Labs develops biotech products for treating staph skin infections in dogs, including Staphage Lysate.
About the Company
Delmont Labs specializes in the development of biotechnological products aimed at treating staphylococcal skin infections, particularly in dogs. Its flagship product, Staphage Lysate (SPL)®, is a unique staphylococcal product approved for canine use. SPL® is designed to reduce the recurrences of staph skin infections and stimulate the immune
system, offering an alternative to prolonged antibiotic treatments. Delmont Labs focuses on enhancing animal health through innovative immunotherapies, demonstrating an increased capability of macrophages to inactivate staphylococci in laboratory animals following SPL treatment.
